| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1950 | 2020 |
| Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C) CN Gruber, RS Patel, R Trachtman, L Lepow, F Amanat, F Krammer, ... Cell 183 (4), 982-995. e14, 2020 | 604 | 2020 |
| MHCflurry: open-source class I MHC binding affinity prediction TJ O'Donnell, A Rubinsteyn, M Bonsack, AB Riemer, U Laserson, ... Cell systems 7 (1), 129-132. e4, 2018 | 418 | 2018 |
| MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing TJ O’Donnell, A Rubinsteyn, U Laserson Cell Systems 11 (1), 42-48. e7, 2020 | 349 | 2020 |
| Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody AG Schmidt, H Xu, AR Khan, T O’Donnell, S Khurana, LR King, ... Proceedings of the National Academy of Sciences 110 (1), 264-269, 2013 | 256 | 2013 |
| OpenFold: Retraining AlphaFold2 yields new insights into its learning mechanisms and capacity for generalization G Ahdritz, N Bouatta, C Floristean, S Kadyan, Q Xia, W Gerecke, ... Nature Methods 21 (8), 1514-1524, 2024 | 252 | 2024 |
| Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors V Roudko, CC Bozkus, T Orfanelli, CB McClain, C Carr, T O’Donnell, ... Cell 183 (6), 1634-1649. e17, 2020 | 191 | 2020 |
| NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer B Salomé, JP Sfakianos, D Ranti, J Daza, C Bieber, A Charap, C Hammer, ... Cancer Cell 40 (9), 1027-1043. e9, 2022 | 91 | 2022 |
| Landscape and selection of vaccine epitopes in SARS-CoV-2 CC Smith, KS Olsen, KM Gentry, M Sambade, W Beck, J Garness, ... Genome medicine 13 (1), 101, 2021 | 55 | 2021 |
| On TCR Binding Predictors Failing to Generalize to Unseen Peptides F Grazioli, A Mösch, P Machart, K Li, I Alqassem, TJ O'Donnell, MR Min Frontiers in Immunology, 6360, 2022 | 51 | 2022 |
| Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer T O’Donnell, EL Christie, A Ahuja, J Buros, BA Aksoy, DDL Bowtell, ... BMC cancer 18, 1-11, 2018 | 44 | 2018 |
| A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti–Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients C Cantarelli, M Jarque, A Angeletti, J Manrique, S Hartzell, T O’Donnell, ... Kidney International Reports 5 (10), 1764-1776, 2020 | 41 | 2020 |
| Bioinformatic methods for cancer neoantigen prediction S Boegel, JC Castle, J Kodysh, T O'Donnell, A Rubinsteyn Progress in Molecular Biology and Translational Science 164, 25-60, 2019 | 40 | 2019 |
| Key mutations stabilize antigen‐binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage H Xu, AG Schmidt, T O'Donnell, MD Therkelsen, TB Kepler, MA Moody, ... Proteins: Structure, Function, and Bioinformatics 83 (4), 771-780, 2015 | 32 | 2015 |
| Predicting Peptide-MHC Binding Affinities With Imputed Training Data A Rubinsteyn, T O'Donnell, N Damaraju, J Hammerbacher bioRxiv, 054775, 2016 | 23 | 2016 |
| TGM4: an immunogenic prostate-restricted antigen ZA Lopez-Bujanda, A Obradovic, TR Nirschl, L Crowley, R Macedo, ... Journal for Immunotherapy of Cancer 9 (6), 2021 | 18 | 2021 |
| High-Throughput MHC I Ligand Prediction Using MHCflurry T O’Donnell, A Rubinsteyn Bioinformatics for Cancer Immunotherapy, 113-127, 2020 | 10 | 2020 |
| Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records TR Pak, KI Chacko, T O’Donnell, SS Huprikar, H van Bakel, A Kasarskis, ... Infection Control & Hospital Epidemiology, 1-9, 2017 | 9 | 2017 |
| Repeat elements amplify TLR signaling T O’Donnell, N Vabret Nature Reviews Immunology 21 (12), 760-760, 2021 | 7 | 2021 |
| Hammerlab/Fancyimpute: Version 0.2. 0 A Rubinsteyn, S Feldman, T O’Donnell, B Beaulieu-Jones Zenodo. doi 10, 2017 | 7 | 2017 |
Alex RubinsteynUniversity of North Carolina - Chapel HillBestätigte E-Mail-Adresse bei openvax.org
